Last edition
News about "Gen Therapies"
US EoE Market Expected to Hit USD 1.19 Billion by 2030, Driven by Next-Gen Therapies
The US market for eosinophilic esophagitis (EoE) is projected to soar from USD 202 million in 2020 to USD 1.19 billion by 2030, reflecting a compound annual growth rate (CAGR) of 19.4 percent, according to GlobalData. This substantial growth is being driven by a transition away from off-label treatments toward FDA-approved, patient-friendly therapies.
Gen Therapies | 25/08/2025 | By Darshana | 148
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy